Veraxa Biotech AG - Post de-SPAC VRXA
NASDAQ VRXA
$1.00 -0.03 (-2.91%)
At close: Oct 23, 2026 · 4:00 PM EDT

Veraxa Biotech AG - Post de-SPAC (VRXA) Total Non-Current Liabilities (2024 - 2025)

Updated

Veraxa Biotech AG - Post de-SPAC's Total Non-Current Liabilities was $112.57 million in the quarter ended Dec 31, 2025, up 92.7% from $58.41 million a year earlier.

Analysis

Veraxa Biotech AG - Post de-SPAC (VRXA) Total Non-Current Liabilities (2024 - 2025) Analysis & Trends

As of Dec 31, 2025, Total Non-Current Liabilities at Veraxa Biotech AG - Post de-SPAC came in at $108.52 million, up 86.6% from the prior year.

  • In earlier years, Total Non-Current Liabilities was $58.16 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 102.65 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 106.45 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 33.91 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 35.10 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 97.04 Bn
10 Veraxa Biotech AG - Post de-SPAC 14.47 Mn 10.90 Mn - 113.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 113.64 Mn
Dec 31, 2024 56.65 Mn
API Access

Veraxa Biotech AG - Post de-SPAC Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=VRXA&period=max&api_key=YOUR_API_KEY